Colin Snow
Amyotrophic lateral sclerosis (ALS) is a fatal neurological disease that causes muscle weakness and sleep disturbances. Sleep is critical for ALS patients, as it ensures the brain can detoxify metabolic wastes and toxins, prevent neuronal degeneration, and promote nerve regeneration. However, ALS patients often experience reduced sleep time, prolonged sleep latency, and an increased number of awakenings due to various factors, such as muscle cramps, respiratory issues, and anxiety or depression. While there is no cure for ALS, treating sleep disturbances and improving sleep quality are crucial for managing symptoms and enhancing patients' quality of life. This includes the use of breathing devices, cough assist machines, medication, and alternative sleeping arrangements. Additionally, research suggests that melatonin may benefit ALS patients by slowing disease progression and improving survival rates, but further studies are needed to confirm these findings.
| Characteristics | Values |
|---|---|
| Treatment for ALS | No cure for ALS |
| Sleep-based therapy | Sleep structural disorders caused by exogenous factors such as cough, excessive oropharyngeal secretions, sleep breathing events, restless leg syndrome, nocturia, muscle stiffness or pain, difficulty turning over, and anxiety or depression |
| Anticholinergic drugs | Atropine and scopolamine |
| Melatonin | May benefit ALS patients, but more research is needed |
| Non-invasive ventilation (NIV) | Use of nocturnal ventilatory assistance (intermittent positive pressure ventilation [IPPV] or bilevel positive airway pressure [BIPAP]) may be used to aid breathing during sleep |
| Riluzole (Rilutek) | First drug treatment for ALS approved by the FDA in 1995; believed to reduce damage to motor neurons by decreasing the release of glutamate |
| Radicava (brand name) or edaravone | Prescription medicine approved for the treatment of ALS by the FDA in 2017 |
| Dazucorilant | Significantly extends survival in Phase 2 ALS trial |
| NeuRx Diaphragm Pacing System | Uses implanted electrodes and a battery pack to cause the diaphragm (breathing muscle) to contract, approved by the FDA |
| Sleep medications | Should be confined to the last phase of the disease prior to death or to intractable insomnia in earlier stages |
| Anti-anxiety medication | May help ALS patients sleep better |
Explore related products
What You'll Learn
Sleep medications should be a last resort
Sleep disturbances are very common in patients with ALS, and constant awareness of sleep-related complaints is important. While there is no cure for ALS, it is crucial to systematically address treatable problems and symptoms to improve or maintain the quality of life of patients.
Instead of immediately resorting to sleeping pills, it is advisable to explore alternative treatments and lifestyle changes to improve sleep quality. For example, non-drug treatments such as cognitive behavioural therapy (CBT) can be beneficial in addressing negative emotional states and thought processes, promoting positive thinking, and implementing effective solutions. Additionally, sleep-based therapy, such as the use of hypnotic drugs, has been suggested as a potential strategy to treat ALS. This approach aims to improve sleep structure and increase non-rapid eye movement (NREM) sleep time, which may delay the development of ALS. Adequate sleep is crucial for patients with ALS as it allows the brain to detoxify metabolic wastes and toxins, prevent neuronal degeneration and necrosis, and promote nerve regeneration.
In some cases, sleep medications may be necessary, especially when other options have been exhausted. When considering the use of sleep medications, it is important to consult a healthcare professional to determine the most appropriate course of action. They can assess the patient's condition, including the severity of symptoms, comorbidities, age, and congenital diseases, to make an informed decision. Additionally, over-the-counter (OTC) sleep aids, such as antihistamines, melatonin, or valerian supplements, can be explored as short-term solutions under the guidance of a healthcare provider.
Valerian Root for Sleep: Natural Aid for Insomnia
You may want to see also
Explore related products
Melatonin may be beneficial
Amyotrophic lateral sclerosis (ALS) is a fatal neurological disease that causes muscle weakness and sleep disturbances. While there is currently no cure for ALS, symptom alleviation and management are important to improve patients' quality of life.
Sleep disturbances are very common in patients with ALS, and these disturbances can aggravate the progression of ALS. Therefore, adequate sleep is crucial for patients with ALS.
Melatonin is a hormone that is naturally produced by the brain in response to darkness, and it helps regulate sleep cycles. Melatonin supplements, available over the counter, are sometimes used to aid sleep. Melatonin has also been found to have antioxidant properties, which can help reduce oxidative stress, a contributing factor in the development and progression of ALS.
A retrospective analysis of the PRO-ACT database, which contains data from 23 ALS clinical trials, found that melatonin use among ALS patients may be associated with slower disease progression and longer survival. Melatonin users in the study had a significantly decreased annualized hazard death rate compared to non-melatonin users. They also had a slower rate of decline in the ALS functional rating scale and forced vital capacity (FVC) scores, a measurement of lung function.
While the study suggests that melatonin may be beneficial for ALS patients, the researchers noted that the findings do not imply a cause-and-effect relationship between melatonin use and improved outcomes. The study had limitations, including a small number of melatonin users and differences between users and non-users prior to treatment. Further research is needed to establish a definitive link between melatonin use and ALS disease progression.
SWAT and Sleeping Gas: A Dangerous Combination
You may want to see also
Explore related products
![GenCare Maximum Strength Nighttime Sleep Aid Supplement for Adults Deep Sleep Pills with Diphenhydramine HCl 50mg to Fall Asleep Faster- Strong Non-Habit Forming PM Sleeping Relief [96 Softgels]](https://m.media-amazon.com/images/I/71WC6IGWvcL._AC_UL320_.jpg)
Anticholinergic drugs can help
Amyotrophic lateral sclerosis (ALS) is a progressive, fatal, degenerative disorder that leads to the death of upper and lower motor neurons. The condition causes advancing weakness of all muscles, and depending on the muscle involved, patients may suffer from reduced mobility, swallowing difficulties, impaired speech, and respiratory muscle weakness. As there is currently no cure for ALS, symptom alleviation is the primary focus of medicine.
Sleep disturbances are very common in patients with ALS, and constant awareness of sleep-related complaints is appropriate. Sleep disorders can aggravate ALS progression, and adequate sleep is crucial to ensure the brain can detoxify metabolic wastes and toxins, avoid neuronal degeneration and necrosis, and promote nerve regeneration. Therefore, sleep-based therapy might be a potential strategy to treat ALS.
Anticholinergic drugs, such as atropine and scopolamine, might be beneficial for ALS patients. Around half of ALS patients exhibit salivation symptoms, and excessive salivation can cause aspiration pneumonia. Anticholinergic drugs reduce salivary gland secretion and salivation. They also increase the heart rate to relieve bradycardia, and they excite the respiratory center to decrease sleep disordered breathing (SDB) events. Several patients with ALS are prone to anxiety and depression symptoms, which usually lead to a low quality of life and accelerate ALS progression. By coincidence, researchers found that intravenous administration of scopolamine results in a rapid and lasting antidepressant effect. Moreover, anticholinergic drugs can also improve microcirculation and provide a stable internal environment for neuronal repair.
Other first-line treatments for sialorrhea include glycopyrrolate, hyoscyamine, and amitriptyline. Transdermal scopolamine patches have shown efficacy in treating ALS-related sialorrhea, reducing oral secretions in a randomized trial. For individuals with refractory sialorrhea, botulinum injections into the salivary glands can be effective.
The Body Shop Sleep Oil: Application and Benefits
You may want to see also
Explore related products
Breathing devices can improve sleep
Amyotrophic lateral sclerosis (ALS) is a fatal neurological disease that causes progressive muscle weakness. ALS patients often experience sleep disturbances due to various factors, including respiratory muscle weakness, which can lead to shallow breathing and carbon dioxide accumulation in the blood. Non-invasive ventilation (NIV) using a facial mask can improve respiratory function and sleep quality in these patients.
Breathing devices, such as Continuous Positive Airway Pressure (CPAP) machines, can effectively improve sleep quality in individuals with sleep disorders, including those with ALS. CPAP machines work by delivering a continuous flow of pressurised air through a tube to a mask, keeping the airways open and stabilising breathing. This reduces breathing interruptions, improves overall sleep quality, and leads to reduced snoring, improved mood, and decreased daytime sleepiness. While some people may find CPAP machines uncomfortable or cumbersome, they are considered the "gold standard" of sleep apnea treatment and can have long-term benefits, including improved blood pressure and reduced risk of cardiovascular events.
In addition to CPAP machines, other breathing devices and therapies can improve sleep. Oral appliances, similar to retainers, can be worn in the mouth to keep the airways open by advancing the jaw. Upper airway exercises can strengthen weak muscles in the tongue and throat, reducing the need for a CPAP machine over time. Surgical options, such as hypoglossal nerve stimulation (INSPIRE therapy), involve the implantation of a pacemaker-sized device to stimulate the hypoglossal nerve and keep the airway open during sleep.
Sleep-based therapy is another potential strategy for treating ALS. Adequate sleep is crucial for the brain to detoxify and promote nerve regeneration. Anticholinergic drugs, such as atropine and scopolamine, can be used to reduce salivation, excite respiratory centres, and improve microcirculation during sleep in ALS patients. Additionally, melatonin has been suggested as a possible treatment for ALS patients, as it acts as an antioxidant, helping to reduce oxidative stress, which is implicated in the development and progression of ALS. While more research is needed, initial studies suggest that melatonin may be associated with slower disease progression and longer survival in ALS patients.
Kratom for Sleep: A Natural Solution?
You may want to see also
Explore related products
Anti-anxiety medication can help
Sleep disturbances are very common in patients with ALS, and constant awareness of sleep-related complaints is appropriate. Since there is no cure for ALS, it is important to systematically look for treatable problems and symptoms to improve or maintain quality of life as much as possible. Sleep disorders can aggravate ALS progression. A decrease in REM sleep can significantly shorten the median survival time of patients with ALS, forming a vicious cycle of insomnia-aggravation-insomnia. Adequate sleep is crucial to ensure the brain can detoxify metabolic wastes and toxins, avoid neuronal degeneration and necrosis, and promote nerve regeneration.
Due to the significant impact of ALS on patients' lives, anxiety and depression are common. These patients may benefit from anti-anxiety medications such as diazepam or lorazepam. Benzodiazepines, such as diazepam suppositories and tablets, or lorazepam are also recommended for patients withdrawing ventilation. Antidepressants with anxiolytic effects could be used for the treatment of anxiety, although other therapy is commonly required. Bupropion is another recommended anti-anxiety medication.
Anticholinergic drugs, such as atropine and scopolamine, might also be beneficial for ALS. Anticholinergic drugs reduce salivary gland secretion and salivation. They also increase the heart rate to relieve bradycardia caused by DEX. They excite the respiratory centre to decrease SDB events during sleep. Researchers found that intravenous administration of scopolamine results in a rapid and lasting antidepressant effect.
In addition to medications, there are several other types of therapies that may be recommended to help relieve and manage ALS symptoms, including physical, occupational, speech, and respiratory therapies.
The Escapists: Using Sleeping Pills to Your Advantage
You may want to see also
Frequently asked questions
There is currently no cure for ALS, and the only drug treatment approved by the FDA is Riluzole (Rilutek), which prolongs survival by several months, mainly in those with difficulty swallowing. However, this drug does not improve sleep quality. While there is no dedicated sleeping pill for ALS patients, physicians can prescribe medications to help with sleep disturbances. These medications aim to reduce fatigue, ease muscle cramps, and control spasticity.
Non-invasive breathing devices such as bilevel positive airway pressure (BiPAP) machines can help ALS patients sleep better. These machines deliver pressurised air through a mask to assist with inhaling and exhaling. Regular use of a bilevel machine can improve quality of life and even prolong life. Adjustable beds can also help ALS patients sleep better by improving positioning and circulation.
Gentle, low-impact aerobic exercise such as walking, swimming, and stationary bicycling can help ALS patients fight fatigue and improve their overall sleep quality. Physical therapists can recommend specific exercises that provide these benefits without overworking the muscles.
Melatonin has been found to have potential benefits for ALS patients, including its ability to act as an antioxidant and reduce oxidative stress, which has been implicated in the development and progression of ALS. Anticholinergic drugs such as atropine and scopolamine might also be beneficial for ALS patients. These drugs reduce salivary gland secretion and salivation, which can improve sleep by reducing the risk of aspiration pneumonia.
